As of December 2024, Lumosa Therapeutics has a market cap of $994.02M. This makes Lumosa Therapeutics the world's 8004th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $801.79M | 132.06% |
2023 | $345.51M | 73.35% |
2022 | $199.31M | -2.11% |
2021 | $203.61M | 14.18% |
2020 | $178.32M | 2.47% |
2019 | $174.02M | 12.97% |
2018 | $154.04M | 3.22% |
2017 | $149.23M | -33.33% |
2016 | $223.84M | -47.32% |
2015 | $424.88M | - |